TP53 and neoplasm: A TP53 wild-type tumor (p = 0.025), AFP concentration ≤ 200 ng/mL (p < 0.001), ECOG performance status of 0 (not 1 or 2) (p = 0.008), BCLC Stage A or B (not C) (p = 0.004), solitary tumor (p = 0.013), and CR on initial follow-up imaging (p = 0.015) were associated with an improved OS.